Outcome of the Board Meeting held on 17th October 2026

BAJAIJ Ref: BHL/ STEX 44/ 2026-27 Date: October 17, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5 Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai — 400001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Sub: Outcome of the Board Meeting held on October 17, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations”) we hereby inform you that the Board of Directors of our Company at its meeting held today i.e. October 17, 2026, has considered and approved the Un-audited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2026 along with the Limited Review Report thereon issued by Walker Chandiok & Co. LLP, Chartered Accountants, Statutory Auditors of the Company in accordance with the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the same is attached herewith. We wish to inform you that the Board Meeting commenced today at 4.00 p.m. and concluded at 4:24 p.m. Kindly take the same on record. Thanking you. Yours faithfully, For and on behalf of Bajaj Healthcare Limited MONICA g2y TANWAR %6553 o0 Monica Tanwar Company Secretary & Compliance Officer Encl: as above BAJAJ HEALTHCARE LTD Registered Office : 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39/A, B-39 A/, Road No. 23, Wagle Ind. Estate, Thane(West), Thane-400 604. © Tel.: + 9122 6617 7400 - 499 * Fax : + 91 22 66177458« Website : www bajajhealth.com CIN No.: L99998MH1993PLC072892 Walker Chandiok &Co LLP Walker Chandiok & Co LLP 16th Floor, Tower I, One International Center, S B Marg, Prabhadevi (W), Mumbai - 400013 Maharashtra, India T +91 22 6626 2600 Independent Auditor's Review Report on Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Bajaj Healthcare Limited 1. We have reviewed the accompanying statement of unaudited financial results (‘the Statement’) of Bajaj Healthcare Limited (‘the Company’) for the quarter ended 30 September 2026 and the year to date results for the period 01 April 2026 to 30 September 2026, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’). 2. The Statement, which is the responsibility of the Company’s management and- approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under section 133 of the Companies Act, 2013 (‘the Act), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Chatered Accountants Walker Chandiok & Co LLP is registered Offcesin Atmedabad, Bengaur, Bhubanesuar, Chancigar, Chennai,Defwadun, Goz, Gurugran, Guvata, Hyderabad,ndore, wih imiled Fabilty wilh idenification daiur Koohi, Kokkta, Mumba,New Del, Ncida and Pune numbar AAC-2085 and has s registered office at L-41, Connaught Circus, Outer Bajaj Healthcare Limited Independent Auditor’s Review Report on Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended 4. Based on our review conducted as above nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Yashwant M. Jain Partner Membership No. 118782 UDIN:- 26118782ILCZXK5585 Place: Mumbai Date: 17 October 2026 Chartered Accountants Walker Chandiok & Co LLP s registered with Offces in Ahmedabad, Bongaluru, Bhubanesviar, Chandigarh, Chenna, Defadun, Goa, Gurugram, Guwahat Hyderabad, Indore, limited ability with identificationnumber Jaipur, Kochi, Kolkala, Murba, New Del, Noida and Pune. AAC-2085 and has ts registered office at L- 41, Connaught Gircus, Outer Circle, New BAJAJ HEALTHCARE LIMITED. (CIN No.: L99999MH1993PLC072892) (Reg. and Corp. Office: 602-808, 6th Floor, Bhoomi Velocity Infotech Park, Above ICICI Bank, Road No. 23, Wagle Industrial Estate, Thane (W) - 400 604) (Tet: +91-22-6617400, Email: investors@bajajhealth.com, Website: www.bajajhealth.com) UN-AUDITED FINANGIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2026 (Rs. In Lakhs except for Earnings Per Share) Partioulars Quarter Ended Period ended Year Ended 30 Sopt 2026] 30 June 2026[30 Sept 2026| 30 Sopt 2026] 30 Sept 2025 [31 March 2026 (Unaudited) | (Unaudited) | (Unauditad) [ (Unaudited) | (Unaudited) | (Audited) A. Continuing operations 1. Revenue from operations 17,690.16| 16,663.17| 14,791.49| 34,153.33| 29,675.12| 61,103.14 . Other income 89.24 81.14 165.29 170.38 253.06 713.39 . Total income (I+11) 17,679.40 | 16,644.31| 14,956.78| 34,023.71| 20,928.18| 61,616.53 IV. Expenses (a) Cost of materials consumod 984121 9,158.91| 7480.50| 19,000.12| 14,468.99| 30,619.95 (b) Changes innventories of finished goods and work-in-progress (703.96) (549.24) (120.39)| (1,263.20)| 949.92 1,019.54 (c) Employee benefits expense 191121 174712 | 1,650.87 3,658.33 3,086.49 6,275.26 (d) Finance costs 597.53 609.10 555.87 1,206.63 1,078.44 222337 (¢) Depreciation and amortisation expense 764.94 701.38 70821 1,466.32 1,271.88 2,754.84 (0 Other expenses 342088| 3331.21| 3,085.61| 6752.09 6023.76] 1270661 Total expenses 15,831.61 | 14,998.48| 13,060.67 | 30,630.29 | 26,879.46 | 5559957 V. Profit before exceptional items and tax expense 1,847.69| 1,645.83| 1,506.21| 3,493.42 3,048.72 6,216.96 V1. Exceptional items - - - - - (3,324.66) VL. Profit beforo tax 1,847.59 | 1,645.83 | 1,596.21| 3,493.42 3,048.72 2,892.30 [VIll. Tax expense (a) Gurrent tax - - - < & - (b) Deferred tax 409.61 256.55 351.35 666.16 586.49 761.26 Total tax expense. 40961 25655 351.35 666.16 586.49 761.26 IX. Profit after tax from continuing operations 1,437.98 | 1,089.28 | 1,044.86| 2,827.26 2,462.23 2,131.04 B. Discontinued operations X. Loss before tax from discontinued operations (Refer note 4) (38.19) (26.03) (179.00) (64.22)] (224.43) (511.69) XI. Tex impact of discontinued operations (9.61) (6.55) (45.06) (16.16) (56.49) a2.74 XIl. Loss after tax from discontinued operations [Showing first 8,000 characters — download PDF for full document]